Zu unserem Team
Geoff Nash
Director
Geoff is a director at Oaklins Cavendish, one of Oaklins’ member firms in the UK, and heads its ECM activities. He has over 20 years’ corporate finance experience in growth companies, having advised on all aspects of IPO, M&A and secondary funding. Geoff has advised clients across a range of sectors, with a particular focus on life sciences. His clients include Avacta plc, Synairgen plc, Bioventix plc and Tristel plc.
Prior to joining the team, Geoff qualified with KPMG and previously worked in private equity. He also spent seven years at Evolution Securities (formerly Beeson Gregory and now part of Investec).
Standort
London, Königreich Großbritannien
E-Mail
g.nash@cavendish.oaklins.com
Telefon
+44 20 7220 0563
London, Königreich Großbritannien
g.nash@cavendish.oaklins.com
Telefon
+44 20 7220 0563
Relevante Transaktionen
Technologie, Medien und Telekommunikation
London Stock Exchange has welcomed Pathos Communications to AIM
Weitere Informationen
Gesundheitswesen
CelLBxHealth has completed an oversubscribed US$10.9 million fundraise
Weitere Informationen
Bau- und Ingenieurdienstleistungen
Amcomri Group has completed an initial public offering
Weitere Informationen
Gesundheitswesen
Oncimmune Holdings plc has placed and converted debt into equity
Weitere Informationen
Gesundheitswesen
IXICO plc has completed a placing, subscription and retail offer
Weitere Informationen
Gesundheitswesen
Creo Medical Group plc has completed a US$15.7 million equity fundraise
Weitere Informationen
Finanzdienstleistungen
FRP Advisory Group plc has finalized a successful secondary placing
Weitere Informationen
Maschinen- & Anlagenbau, Komponenten
Xeros Technology Group has completed a placing, subscription and retail offer
Weitere Informationen
Technologie, Medien und Telekommunikation











